Annual Total Expenses
$9.52 M
-$10.86 M-53.30%
December 31, 2023
Summary
- As of February 8, 2025, AMPE annual total expenses is $9.52 million, with the most recent change of -$10.86 million (-53.30%) on December 31, 2023.
- During the last 3 years, AMPE annual total expenses has fallen by -$6.32 million (-39.89%).
- AMPE annual total expenses is now -69.73% below its all-time high of $31.45 million, reached on December 31, 2014.
Performance
AMPE Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$2.21 M
+$815.00 K+58.21%
December 31, 2023
Summary
- As of February 8, 2025, AMPE quarterly total expenses is $2.21 million, with the most recent change of +$815.00 thousand (+58.21%) on December 31, 2023.
- Over the past year, AMPE quarterly total expenses has dropped by -$486.00 thousand (-17.99%).
- AMPE quarterly total expenses is now -78.88% below its all-time high of $10.49 million, reached on March 31, 2014.
Performance
AMPE Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
AMPE Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.3% | -18.0% |
| 3 y3 years | -39.9% | -43.4% |
| 5 y5 years | -14.9% | -12.7% |
AMPE Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -53.7% | at low | -76.0% | +58.2% |
| 5 y | 5-year | -53.7% | at low | -76.0% | +58.2% |
| alltime | all time | -69.7% | >+9999.0% | -78.9% | >+9999.0% |
Ampio Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $9.52 M(-53.3%) | $2.21 M(+58.2%) |
| Sep 2023 | - | $1.40 M(-10.3%) |
| Jun 2023 | - | $1.56 M(-64.1%) |
| Mar 2023 | - | $4.34 M(+60.8%) |
| Dec 2022 | $20.38 M(-0.9%) | $2.70 M(-52.8%) |
| Sep 2022 | - | $5.72 M(+14.7%) |
| Jun 2022 | - | $4.99 M(-28.4%) |
| Mar 2022 | - | $6.96 M(-24.5%) |
| Dec 2021 | $20.57 M(+29.9%) | $9.23 M(+139.6%) |
| Sep 2021 | - | $3.85 M(+4.8%) |
| Jun 2021 | - | $3.67 M(-3.8%) |
| Mar 2021 | - | $3.82 M(-2.4%) |
| Dec 2020 | $15.83 M(-14.8%) | $3.91 M(+18.4%) |
| Sep 2020 | - | $3.30 M(+27.0%) |
| Jun 2020 | - | $2.60 M(-56.8%) |
| Mar 2020 | - | $6.02 M(-15.7%) |
| Dec 2019 | $18.58 M(+66.1%) | $7.15 M(+38.1%) |
| Sep 2019 | - | $5.17 M(+44.5%) |
| Jun 2019 | - | $3.58 M(+33.8%) |
| Mar 2019 | - | $2.68 M(+5.5%) |
| Dec 2018 | $11.18 M(-28.7%) | $2.54 M(+30.8%) |
| Sep 2018 | - | $1.94 M(-38.0%) |
| Jun 2018 | - | $3.13 M(-12.4%) |
| Mar 2018 | - | $3.57 M(-25.7%) |
| Dec 2017 | $15.68 M(-8.2%) | $4.81 M(+55.0%) |
| Sep 2017 | - | $3.11 M(-33.8%) |
| Jun 2017 | - | $4.69 M(+56.2%) |
| Mar 2017 | - | $3.00 M(+1.9%) |
| Dec 2016 | $17.08 M(-29.3%) | $2.95 M(-11.8%) |
| Sep 2016 | - | $3.34 M(-23.4%) |
| Jun 2016 | - | $4.37 M(-32.0%) |
| Mar 2016 | - | $6.42 M(-12.0%) |
| Dec 2015 | $24.17 M | $7.29 M(+37.6%) |
| Sep 2015 | - | $5.30 M(-8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $5.78 M(-0.2%) |
| Mar 2015 | - | $5.79 M(+133.7%) |
| Dec 2014 | $31.45 M(+30.6%) | $2.48 M(-74.0%) |
| Sep 2014 | - | $9.52 M(+6.2%) |
| Jun 2014 | - | $8.96 M(-14.5%) |
| Mar 2014 | - | $10.49 M(+38.9%) |
| Dec 2013 | $24.07 M(+102.8%) | $7.55 M(+26.8%) |
| Sep 2013 | - | $5.96 M(-7.9%) |
| Jun 2013 | - | $6.47 M(+57.8%) |
| Mar 2013 | - | $4.10 M(+8.7%) |
| Dec 2012 | $11.87 M(+6.4%) | $3.77 M(+34.0%) |
| Sep 2012 | - | $2.81 M(+23.5%) |
| Jun 2012 | - | $2.28 M(-24.3%) |
| Mar 2012 | - | $3.01 M(-34.0%) |
| Dec 2011 | $11.15 M(+66.4%) | $4.56 M(+64.3%) |
| Sep 2011 | - | $2.78 M(+76.1%) |
| Jun 2011 | - | $1.58 M(-29.5%) |
| Mar 2011 | - | $2.24 M(+35.7%) |
| Dec 2010 | $6.70 M(+343.5%) | $1.65 M(-32.2%) |
| Sep 2010 | - | $2.43 M(+112.7%) |
| Jun 2010 | - | $1.14 M(-22.7%) |
| Mar 2010 | - | $1.48 M(+151.3%) |
| Dec 2009 | $1.51 M(+5076.4%) | $588.60 K(+14.2%) |
| Sep 2009 | - | $515.20 K(+26.4%) |
| Jun 2009 | - | $407.70 K(+9607.1%) |
| Dec 2008 | $29.20 K(-6.4%) | $4200.00(-34.4%) |
| Sep 2008 | - | $6400.00(+137.0%) |
| Jun 2008 | - | $2700.00(-83.1%) |
| Mar 2008 | - | $16.00 K(+88.2%) |
| Dec 2007 | $31.20 K(+3020.0%) | $8500.00(+16.4%) |
| Sep 2007 | - | $7300.00(-51.7%) |
| Jun 2007 | - | $15.10 K(+4933.3%) |
| Mar 2007 | - | $300.00(0.0%) |
| Dec 2006 | $1000.00 | $300.00(0.0%) |
| Sep 2006 | - | $300.00 |
FAQ
- What is Ampio Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual total expenses year-on-year change?
- What is Ampio Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly total expenses year-on-year change?
What is Ampio Pharmaceuticals annual total expenses?
The current annual total expenses of AMPE is $9.52 M
What is the all time high annual total expenses for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual total expenses is $31.45 M
What is Ampio Pharmaceuticals annual total expenses year-on-year change?
Over the past year, AMPE annual total expenses has changed by -$10.86 M (-53.30%)
What is Ampio Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of AMPE is $2.21 M
What is the all time high quarterly total expenses for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly total expenses is $10.49 M
What is Ampio Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, AMPE quarterly total expenses has changed by -$486.00 K (-17.99%)